Tempus AI Investors Alerted by Former Louisiana AG Regarding Class Action Lawsuit Details

Investor Alert for Tempus AI Shareholders

In a recent announcement, Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., has alerted investors regarding a significant development affecting Tempus AI, Inc. Investors who have sustained losses exceeding $100,000 during the class period from August 6, 2024, to May 27, 2025, are being prompted to act. If you purchased shares during this timeframe, it is crucial to understand your rights and the options available.

The call to action highlights that affected shareholders have until August 12, 2025, to file their applications to serve as lead plaintiffs in the ongoing securities class action lawsuit against Tempus AI. The case is currently being pursued in the United States District Court for the Northern District of Illinois, and it revolves around allegations that Tempus AI and some of its executives failed to disclose material information that could mislead investors, thus violating federal securities laws.

Background of the Allegations

The lawsuit began following revelations by Spruce Point Capital Management, which raised numerous concerns regarding Tempus AI's management practices, operational tactics, and financial disclosures. Reportedly, these concerns include:
1. History of Cashing Out: There are claims that Tempus CEO Eric Lefkofsky and his associates have a track record of selling off shares prior to public losses, potentially at the detriment of shareholders.
2. Exaggerated AI Capabilities: Allegations include overstated claims about Tempus AI's artificial intelligence capabilities that could mislead investors about the company’s operations.
3. Executive Associations: A number of Tempus executives have reportedly been linked to other troubled enterprises that faced scrutiny over their financial reporting, raising red flags about accountability within Tempus AI.
4. Aggressive Accounting Practices: Financial reports suggest there may be problematic accounting practices in play, which could indicate larger issues within the company.
5. Concerns with Partnerships: Issues have been flagged regarding Tempus' dealings with AstraZeneca and the Pathos AI project, suggesting further investigation is warranted.
6. Weak Financial Guidance: A recent downward revision of the company's financial outlook was noted, which could indicate underlying weaknesses in its core operations.

Upon these alarming disclosures, Tempus AI's stock price saw a sharp decline, dropping by $12.67 per share—or roughly 19.23%, plummeting from $65.87 to $53.20 in a single day. This decline serves as a stark reminder of the volatility in the market.

Next Steps for Investors

For investors holding Tempus AI shares, immediate action is advised. Interested parties are encouraged to reach out to KSF Managing Partner Lewis Kahn, who is available for a no-cost, obligation-free discussion about the potential impacts of the lawsuit on their investments. Investors can contact him toll-free at 1-877-515-1850 or through email contact at [email protected]. Additionally, further details and procedural steps can be accessed by visiting Kahn Swick & Foti's dedicated webpage.

If you wish to assume a pivotal role as lead plaintiff in this class action litigation, the deadline for court petitioning is set for August 12, 2025. Acting swiftly could provide you with the opportunity to recover losses incurred during this tumultuous financial chapter for Tempus AI.

Law Firm Background

Kahn Swick & Foti, LLC is regarded as one of the leading boutique securities litigation firms in the nation, championing various institutional and retail investors in their fight against corporate malfeasance. The firm’s robust track record includes securing substantial settlements for clients impacted by fraudulent corporate practices. For additional information about KSF's services and commitment to protecting investor rights, visit their official website at www.ksfcounsel.com.